News

By Priscila Mayumi Kashiwabara

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.

Access the full guide, published by IAM and written by Priscila Kashiwabara, Marisa Momoli and Livia Figueiredo by clicking here.
Back

Last by Priscila Mayumi Kashiwabara

December 2, 2024

Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty

On November 27, 2024, the Chamber of Deputies approved Bill 466/2022, which addresses Brazil’s adhesion to the Budapest Treaty on the International Brazil’s Chamber of Deputies approves adhesion to the Budapest Treaty

Ler notícia

September 23, 2024

Priscila Kashiwabara will be attending “From Gene to Trait 2024” course

Our partner Priscila Kashiwabara will be one of the speakers at the “From Gene to Trait 2024” course. The event will take Priscila Kashiwabara will be attending “From Gene to Trait 2024” course

Ler notícia

September 9, 2024

Kasznar Leonardos wins LMG Life Sciences

We are honored to announce that Kasznar Leonardos has won the Firm of the Year: Brazil award at the LMG Life Sciences! Kasznar Leonardos wins LMG Life Sciences

Ler notícia
plugins premium WordPress